GOUR MEDICAL Information Meeting: Products, Strategy, Perspectives
On the occasion of its half-yearly activity, Dr. Loïc MAUREL, Scientific Director & Corporate Development of GOUR MEDICAL, is pleased to invite you to an information meeting on
Tuesday, July 9, from 6 pm
24 rue de Mogador - 75009 PARIS (M ° L12 - Trinité d'Estienne d'Orves).
The meeting will feature Weedley, Europe's first full-spectrum cannabidiol-based premium solutions for pets, as well as the company's strategy and outlooks.
The number of places being limited, we thank you in advance to kindly confirm your presence by clicking here.
Next meeting :
Tuesday, July 9, 2019: Activity of the first half of 2019 and information meeting (after-market)
Find all the information on Gour Medical:
and on Weedley:
About GOUR MEDICAL
Founded in 2014, GOUR MEDICAL specializes in the development and commercialization of innovative veterinary solutions for pets. Its unique positioning and expertise in the stock market rely on the use of non-psychoactive molecules contained in hemp, such as cannabidiol, seeds, terpenes, to target the long-term management of pain, especially osteoma. osteoarthritis, stress and anxiety.
Result of several years of research and work, its first European range, marketed under the Weedley brand, increases the surrounding effect by a "full spectrum" approach and contains no GMOs, preservatives or heavy metals.
Gour Medical shares are listed on Euronext Paris (FR0013371507 - MLGML) and are eligible for the PEA-PME.
Scientific Director & Corporate Development
Cell. : +33 786 449 642
Edouard de MAISSIN
Cell. : +33 683 485 567 Mail : firstname.lastname@example.org